Alternate-day administration of pegvisomant maintains normal serum insulin-like growth factor-I levels in patients with acromegaly. (Q53877566)
Jump to navigation
Jump to search
scientific article published on 7 December 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alternate-day administration of pegvisomant maintains normal serum insulin-like growth factor-I levels in patients with acromegaly. |
scientific article published on 7 December 2004 |
Statements
Alternate-day administration of pegvisomant maintains normal serum insulin-like growth factor-I levels in patients with acromegaly. (English)
1 reference
Sigrid Jehle
1 reference
Carlos M Reyes
1 reference
Robert E Sundeen
1 reference
Pamela U Freda
1 reference
7 December 2004
1 reference
90
1 reference
3
1 reference
1588-1593
1 reference
Identifiers
1 reference